OVERVIEW/COURSE DESCRIPTION

REGISTER HERE

The one-day symposium will consist of lectures that will provide a comprehensive overview of metastatic central nervous system disease for the physician and support staff, followed by treatment sections that highlight current practices as well as novel approaches to longstanding problems, particularly in the era of immunotherapy and stereotactic radiation.

EDUCATIONAL OBJECTIVE 

By the conclusion of this activity, participants should be able to:
• Indicate the basic biology and epidemiology of brain mets • Determine how to treat patients with CNS mets either with surgery, chemotherapy, and/or radiation • Master the basics of radiation biology and physics relevant for oncologists • Identify how and when to refer patients to subspecialty oncologists • Classify brain and spine mets • Choose the options for pain relief in the cancer patient • Characterize the potential synergy between radiation and immunotherapy • Recognize the role of immunotherapy in patients with brain metastases

TARGET AUDIENCE

This CME course is intended for neurosurgeons, neuro-oncologists, medical oncologists, radiation oncologists, neurologists, orthopedic surgeons, internists, general practitioners, and geriatricians.

ACCREDITATION AND CREDIT DESIGNATION STATEMENTS 

Weill Cornell Medical College is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Weill Cornell Medical College designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

COURSE AGENDA

• 7:30am-8:00am Breakfast/Registration Belfer Research Building
• 8:00am-8:05am Welcome Philip E. Stieg, Ph.D., M.D., and Rohan Ramakrishna, M.D.
• 8:05am-8:30am Classification of Brain Mets Paul Sperduto, M.D.
• 8:30am-8:50am Imaging Assessment of Brain Mets Gloria Chia-Yi Chiang, M.D.
• 8:50am-9:15am Role of Precision Oncology for Brain Mets Justine Cohen, M.D.
• 9:15am-10:15am Chemotherapy for Brain Mets 
  • Lung  Manmeet Ahluwalia, M.D. 
  • Breast  Ari Morikawa, M.D. 
  • Melanoma   Paul Chapman, M.D.
• 10:15am-10:25am Q & A Rohan Ramakrishna, M.D.
• 10:25am-10:40am BREAK
• 10:40am-11:00am Management of Leptomeningeal Disease Adrienne Boire, M.D.
• 11:00am-11:20am Surgery and Its Role Rohan Ramakrishna, M.D.
• 11:20am-11:40pm WBRT and Its Role Jonathan Knisely, M.D.
• 11:40pm-12:00pm SRS and Its Role Susan Pannullo, M.D.
• 12:00pm-1:00pm LUNCH 1:00pm-1:25pm Controversies in SRS Douglas Kondziolka, M.D.
• 1:25pm-1:50pm Neuropsychological Sequelae of Brain Mets   and Their Treatment and Preventive Strategies Jeffrey Scott Wefel, M.D.
• 1:50pm-2:10pm Role of Brachytherapy Theodore Schwartz, M.D.
• 10pm-2:35pm Radiatin Necrosis and LITT Veronica Chiang, M.D.
• 2:35pm-2:55pm SRS and Immunotherapy Silvia Formenti, M.D.
• 2:55pm-3:05pm BREAK
• 3:05pm-3:25pm Management of Seizures in Patients with Brain Mets Rajiv Magge, M.D.
• 3:25pm-3:45pm Palliative Care Needs in Patients with Brain Mets Milagros Silva, M.D.